BIOSINTEZ PAO |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 14-10-27 | |
Arvind Abrol
BRD | Director/Board Member | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Arvind Abrol
BRD | Director/Board Member | 52 | - |
| Chairman | 48 | - | |
Arvind Kumar
BRD | Director/Board Member | 53 | - |
Biosintez PAO, formerly Biosintez OAO, is a Russia-based company engaged in the pharmaceuticals industry. The Company manufactures tablets, ointments, suppositories, powders for injections, injections in ampoules, and bottles. It produces approximately 180 types of drug and pharmaceutical preparations from such pharmaceutical groups as: antibiotics; antimicrobial agents; bronchodilators; vitamins; hypoglycemic agents; diuretics; blood substitutes; anti-allergens and antiviral agents; anti-inflammatory, analgesic and antipyretics; sedatives, and anti-tuberculosis drugs, among others. The Company sells its products on the domestic market, as well as exports them, mainly to the Commonwealth of Independent States (CIS).
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +18.04% | 43.07B | |
| +16.92% | 21.51B | |
| +18.33% | 15.19B | |
| +19.27% | 14.44B | |
| +56.12% | 13.12B | |
| -10.73% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +4.00% | 4.73B |
- Stock Market
- Equities
- Stock
